Home >  Cancer Center Home >  Services >  Pathology



The Department of Pathology at Montefiore Medical Center is one of the largest and most comprehensive medical center laboratories on the East Coast. With a staff of more than 50 pathologists and doctoral researchers, our laboratories generate more than 10,000,000 laboratory test results, interpretations and diagnostic consultations each year.

As part of our multidisciplinary approach to cancer care, our Pathology Department is involved in clinical services and research. Our patients have access to many cancer services, including:

Anatomical Pathology

Anatomical pathology involves the removal of tissue during a surgical procedure, followed by diagnostics to detect cancer and establish which type is present.

Cancer Screening

Our pathologists conduct cancer screening in cooperation with clinicians, and include:

  • Cytopathology tests to analyze cell structure to diagnose disease
  • Pap smears
  • Biopsies
  • Prostate (PSA) testing

Cancer pathologists also sit on Tumor Boards for the collaborative care, planning and treatment of each patient.

Quicker Diagnosis, Faster Treatment

At Montefiore, we understand how stressful it can be to wait for your lab test results. Using an advanced software program developed by Tylis Chang, MD, we are better able to monitor the flow of information coming into all of our pathology labs. We can easily track appointment turnaround times, monitor performance, improve quality control, reduce medical errors and determine appropriate staffing needs for research studies. As a hospital committed to excellence, we are unwavering in our determination to deliver accurate results as quickly as possible.

Cancer Biology Research

Cross-campus pathology research programs between Montefiore and Albert Einstein College of Medicine are highly interactive and collaborative, focusing on:

  • Translation of basic science discoveries into clinical practice
  • Development of molecular database to create signatures to personalize a patient's medical treatment
  • Genomic and proteomic approaches to predicting tumor behavior
  • Cancer biomarkers
  • Stem cell deregulation in lung cancer
  • Transcriptional control of tumor promotion in the liver
  • Histological risk assessment in squamous cell carcinoma
  • Clinical diagnostic and prognostic head and neck cancer imaging tools to determine differences between aggressive and nonaggressive tumors
  • Adhesion and signaling in breast cancer metastasis
  • Vitamin D testing